NCT07460232 2026-03-10
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Mayo Clinic
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
29 trialsNCT05636540 2026-02-27
In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Recruiting
NCT04993261 2026-02-19
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06639191 2026-01-30
AKIR001
Karolinska University Hospital
Phase EARLY_PHASE1 Recruiting
NCT03541720 2025-12-03
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
St. Jude Children's Research Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT07132645 2025-09-23
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03335670 2025-07-14
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
University of Iowa
Phase EARLY_PHASE1 Active not recruiting
NCT03085056 2025-07-03
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04544098 2025-05-02
Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04510311 2025-01-10
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT01873248 2024-07-19
Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT05359146 2024-04-19
Beta plus
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Recruiting
NCT05069220 2024-03-01
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Recruiting
NCT06217848 2024-01-23
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Seoul National University Hospital
Phase EARLY_PHASE1 Unknown
NCT03724409 2023-11-28
Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
University of Iowa
Phase EARLY_PHASE1 Terminated
NCT05871320 2023-09-29
TECANT
Jagiellonian University
Phase EARLY_PHASE1 Completed
NCT04897542 2023-09-18
Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT03623984 2023-09-11
Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers
University of Alabama at Birmingham
Phase EARLY_PHASE1 Withdrawn
NCT03044977 2023-08-16
Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors
University of Iowa
Phase EARLY_PHASE1 Active not recruiting
NCT05034783 2022-10-14
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT05361083 2022-05-04
First-in-human Evaluation of [18F]CETO
Uppsala University
Phase EARLY_PHASE1 Completed
NCT02817945 2022-04-07
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT04804163 2022-02-16
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery
The Affiliated Hospital of Qingdao University
Phase EARLY_PHASE1 Completed
NCT03647657 2022-02-10
177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Completed
NCT03001349 2021-02-15
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03197012 2020-07-07
Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT04185350 2019-12-04
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Nanjing First Hospital, Nanjing Medical University
Phase EARLY_PHASE1 Unknown
NCT04041882 2019-08-01
68Ga-DOTATATE PET/CT in Neuroendocrine Tumor
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT02493959 2015-07-10
Degradation of the Anorexic Hormone Peptide YY
Hvidovre University Hospital
Phase EARLY_PHASE1 Completed